10-119651688-A-G
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The NM_004281.4(BAG3):āc.13A>Gā(p.Thr5Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000012 in 1,582,766 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004281.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BAG3 | NM_004281.4 | c.13A>G | p.Thr5Ala | missense_variant | 1/4 | ENST00000369085.8 | NP_004272.2 | |
BAG3 | XM_005270287.2 | c.13A>G | p.Thr5Ala | missense_variant | 1/4 | XP_005270344.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BAG3 | ENST00000369085.8 | c.13A>G | p.Thr5Ala | missense_variant | 1/4 | 1 | NM_004281.4 | ENSP00000358081 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151768Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000775 AC: 17AN: 219398Hom.: 0 AF XY: 0.0000744 AC XY: 9AN XY: 121004
GnomAD4 exome AF: 0.0000119 AC: 17AN: 1430998Hom.: 0 Cov.: 31 AF XY: 0.0000112 AC XY: 8AN XY: 711706
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151768Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74114
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 21, 2016 | A variant of uncertain significance has been identified in the BAG3 gene. The T5A variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The T5A variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Though also not observed in these aforementioned populations by the Exome Aggregation Consortium (ExAc), ExAc did observe T5A in 8/10634 (0.08%) alleles from individuals of Latino background. The T5A variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved in mammals. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. - |
Dilated cardiomyopathy 1HH Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Jul 09, 2020 | - - |
Myofibrillar myopathy 6;C3151293:Dilated cardiomyopathy 1HH Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 12, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at